GlassScriptPhysician profile
Shi Cheng
NPI 1730251653
$10,236.39
in general payments reported to CMS, 2019-2025
35 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $306 · 2021: $1,003 · 2022: $1,903 · 2023: $2,251 · 2024: $1,852 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,388 · Education: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,388.20 |
| Education | $601.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,259.72 | 2022-2025 | Tremfya |
| Abbvie INC. | $1,166.45 | 2019-2025 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $918.59 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $905.24 | 2021-2025 | Dupixent, Libtayo |
| Pfizer INC. | $804.52 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $733.67 | 2019-2025 | |
| Amgen INC. | $641.63 | 2020-2025 | Otezla, Otezla |
| Lilly USA, LLC | $509.26 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $408.73 | 2021-2025 | Opzelura |
| Ucb, INC. | $403.36 | 2019-2025 | Bimzelx, Cimzia |
| Leo Pharma INC. | $384.83 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $383.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $352.88 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $238.55 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $204.43 | 2019-2025 | Cabtreo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $114.29 | 2020-2023 | Aklief, Epsolay, Oracea |
| Mayne Pharma Commercial LLC | $87.01 | 2019-2025 | |
| Dermavant Sciences, INC. | $82.53 | 2022-2024 | Vtama |
| Biofrontera INC. | $80.76 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Sanofi-Aventis U.S. LLC | $69.99 | 2023 | |
| Epi Health, LLC | $65.28 | 2019-2022 | |
| Dermira, INC. | $55.84 | 2019-2020 | |
| Organogenesis INC. | $50.94 | 2023 | Puraply |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.88 | 2024 | Spevigo |
| Celgene Corporation | $43.18 | 2019 | |
| Almirall LLC | $38.05 | 2023-2024 | Klisyri, Seysara |
| Organon LLC | $35.92 | 2025 | |
| Sensus Healthcare, INC. | $24.85 | 2021 | |
| Botanix Sb INC | $21.23 | 2025 | Sofdra |
| Nabriva Therapeutics, Plc | $21.13 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.60 | 2019 | |
| Verrica Pharmaceuticals INC. | $17.58 | 2023 | Ycanth |
| Journey Medical Corporation | $17.40 | 2022 | |
| Vyne Pharmaceuticals INC. | $14.25 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shi Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.